IL13 and pulmonary emphysema: In transgenic mice overexpressing IL-13, matrix metalloprotease (MMP)- 2, -9, -12, -13, and -14, and cathepsins B, L, S, H, and K were upregulated and treatment with MMP and cysteine proteinase antagonists significantly decreased the emphysema [15].